Bartlett & Co’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$946K Buy
4,373
+1,355
+45% +$289K 0.02% 281
2023
Q3
$604K Hold
3,018
0.01% 313
2023
Q2
$559K Buy
3,018
+40
+1% +$7.39K 0.01% 331
2023
Q1
$570K Hold
2,978
0.01% 275
2022
Q4
$514K Sell
2,978
-9
-0.3% -$1.56K 0.01% 286
2022
Q3
$529K Sell
2,987
-36
-1% -$7.12K 0.01% 276
2022
Q2
$619K Buy
3,023
+143
+5% +$30.3K 0.01% 255
2022
Q1
$685K Hold
2,880
0.01% 262
2021
Q4
$667K Buy
2,880
+2,700
+1,500% +$594K 0.01% 269
2021
Q3
$35K Sell
180
-107
-37% -$21.7K ﹤0.01% 554
2021
Q2
$61K Hold
287
﹤0.01% 474
2021
Q1
$59K Buy
287
+100
+53% +$19.7K ﹤0.01% 506
2020
Q4
$34K Buy
187
+7
+4% +$1.19K ﹤0.01% 593
2020
Q3
$30K Hold
180
﹤0.01% 562
2020
Q2
$29K Hold
180
﹤0.01% 559
2020
Q1
$31K Buy
+180
New +$35.8K ﹤0.01% 532
2019
Q3
$38K Buy
180
+173
+2,471% +$36.1K ﹤0.01% 574
2019
Q2
$1K Buy
7
+2
+40% +$369 ﹤0.01% 698
2019
Q1
$1K Buy
+5
New +$884 ﹤0.01% 670

Other funds holding CME

Bartlett & Co's CME Position: Q4 2023 in Review

Bartlett & Co increased its CME Group (CME) stake by 45% in Q4 2023, buying an estimated $289K and bringing the position to 4,373 shares worth $946K. The position accounts for 0.02% of the portfolio, ranked #281.

Bartlett & Co first reported a position in CME in Q1 2019 and has held it in 19 quarters since. 1,361 funds tracked by Wall St. Rank hold CME as of Q4 2023.

  • Bartlett & Co held 4,373 shares of CME Group worth $946K as of Q4 2023.
  • Bartlett & Co bought 1,355 CME Group shares in Q4 2023, an estimated $289K.
  • CME Group made up 0.02% of Bartlett & Co's portfolio in Q4 2023, its #281 holding.
  • Bartlett & Co first reported a position in CME Group in Q1 2019 and has held it in 19 quarters since.
  • 1,361 funds tracked by Wall St. Rank held CME Group as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.